Advertisement
Biodeal Pharmaceuticals
Premium
Healthcare
11 August, 2026
Contract drugmaker Biodeal snags fresh funding, eyes new markets
Biodeal Pharmaceuticals Ltd, the contract development and manufacturing organisation (CDMO) that last month provided an ......
Premium
Healthcare
27 July, 2026
Piramal Alternatives exits healthcare investment through performing credit fund
Piramal Alternatives, the fund management arm of the Piramal Group, has exited its investment in a drugmaker after ......
Healthcare
08 April, 2024
Piramal Alternatives invests $13.2 mn in contract drugmaker Biodeal
Piramal Alternatives, the fund management arm of the Piramal Group, has announced a Rs 110-crore ($13.2 million) ......
Advertisement
Most Popular
Advertisement
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News